Drug reverses accelerated aging
July 5, 2011
An immune-suppressing drug called rapamycin could possibly treat Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disease that causes premature aging, and advance biological understanding of the normal aging process, according to researchers from the National Human Genome Research Institute (NHGRI) at the National Institutes of Health, the University of Maryland and Massachusetts General Hospital.
Progeria is a genetic disorder characterized by dramatic premature aging.
“Progerin that causes progeria also accumulates, although in very small amounts, in normal aging,” said Dimitri Krainc, M.D., Ph.D., associate professor of neurology at Harvard Medical School. “However, if rapamycin proves to have beneficial effects in lifespan in humans it is safe to assume that it will not be just because it may clear progerin from cells, but also because it clears other toxic products that accumulate during aging.”
Global Source and/or and/or more resources and/or read more: http://goo.gl/JujXk ─ Publisher and/or Author and/or Managing Editor:__Andres Agostini ─ @Futuretronium at Twitter! Futuretronium Book at http://goo.gl/JujXk